Evidence map›Paper›PMID 22837677›Full record

ArticleInternational journal of molecular sciences2012

Toward the prediction of FBPase inhibitory activity using chemoinformatic methods.

Ming Hao, Shuwei Zhang, Jieshan Qiu

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Nature is the best source of anti-inflammatory drugs: indexing natural products for their anti-inflammatory bioactivity.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2018
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ming HaoDepartment of Materials Science and Chemical Engineering, Dalian University of Technology, Dalian 116023, Liaoning, China.
Shuwei ZhangDepartment of Materials Science and Chemical Engineering, Dalian University of Technology, Dalian 116023, Liaoning, China.
Jieshan QiuDepartment of Materials Science and Chemical Engineering, Dalian University of Technology, Dalian 116023, Liaoning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, Chemoinformatic methods are used to perform the prediction for FBPase inhibitory activity. A genetic algorithm-random forest coupled method (GA-RF) was proposed to predict fructose 1,6-bisphosphatase (FBPase) inhibitors to treat type 2 diabetes mellitus using the Mold(2) molecular descriptors. A data set of 126 oxazole and thiazole analogs was used to derive the GA-RF model, yielding the significant non-cross-validated correlation coefficient r(2) (ncv) and cross-validated r(2) (cv) values of 0.96 and 0.67 for the training set, respectively. The statistically significant model was validated by a test set of 64 compounds, producing the prediction correlation coefficient r(2) (pred) of 0.90. More importantly, the building GA-RF model also passed through various criteria suggested by Tropsha and Roy with r(2) (o) and r(2) (m) values of 0.90 and 0.83, respectively. In order to compare with the GA-RF model, a pure RF model developed based on the full descriptors was performed as well for the same data set. The resulting GA-RF model with significantly internal and external prediction capacities is beneficial to the prediction of potential oxazole and thiazole series of FBPase inhibitors prior to chemical synthesis in drug discovery programs.

Indexed as

AlgorithmsComputational BiologyComputer SimulationDiabetes Mellitus, Type 2Drug DiscoveryFructose-BisphosphataseHumansInhibitory Concentration 50Models, MolecularModels, StatisticalOxazolesQuantitative Structure-Activity RelationshipRegression AnalysisFructose-BisphosphataseOxazoleschemoinformatics methodsFBPase inhibitorgenetic algorithmrandom forest

Identifiers

PMID22837677
PMCPMC3397509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.